Check out our latest #whitepaper containing clinical trial data, real-world evidence, and example algorithms that detail how T2Candida can be incorporated into practice and improve care for invasive candidiasis in your own practice.
- March 31, 2023
The presentation discusses the current challenges in detecting sepsis-causing pathogens and how the use of non-culture-based-tests like T2Bacteria and T2Candida provide faster and more accurate results than the current standard of care, which relies on a positive blood culture.1
Speakers: Dr. Debra Goff, PharmD, FCCP, from The Ohio State University Wexner Medical Center and Dr. Aparna Ahuja, the Chief Medical Officer of T2 Biosystems
1. Nguyen, M. H., et al. Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections. A Diagnostic Accuracy Study. Annals of Internal Medicine. 2019.